A recent research study found that a combination of the GLP-1 receptor agonist semaglutide and bimagrumab, an antibody that ...
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Veru said Monday that its ...
A gastroenterologist warns GLP-1 weight-loss drugs may cause hidden muscle loss. Experts explain risks and how to protect lean mass during rapid weight loss.
There's no question that glucagon-like peptide 1 (GLP-1) agonists represent a major advance in the treatment of obesity for patients with or without diabetes. In clinical trials, participants lost 15% ...
While GLP-1 drugs are effective for shedding pounds, there are concerns about potential risks and long-term effects.
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Scholar Rock said ...